140 related articles for article (PubMed ID: 38212669)
1. Incidence of cardiovascular disease in healthy Swedish peripheral blood stem cell donors - a nationwide study.
Pahnke S; Hägglund H; Larfors G
Bone Marrow Transplant; 2024 Mar; 59(3):403-408. PubMed ID: 38212669
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence in healthy Swedish peripheral blood stem cell donors.
Pahnke S; Nygell UA; Johansson JE; Kisch A; Ljungman P; Sandstedt A; Hägglund H; Larfors G
Bone Marrow Transplant; 2022 May; 57(5):795-802. PubMed ID: 35256742
[TBL] [Abstract][Full Text] [Related]
3. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors.
Cao J; Li A; Pei R; Lu Y; Chen D; Du X; Liu X; Li S; Ye P
Ann Hematol; 2023 Dec; 102(12):3567-3573. PubMed ID: 37773294
[TBL] [Abstract][Full Text] [Related]
5. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
6. Immunological Heterogeneity of Healthy Peripheral Blood Stem Cell Donors-Effects of Granulocyte Colony-Stimulating Factor on Inflammatory Responses.
Tvedt THA; Melve GK; Tsykunova G; Ahmed AB; Brenner AK; Bruserud Ø
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249022
[TBL] [Abstract][Full Text] [Related]
7. Lower platelet count with increased density of platelet antigens in granulocyte colony-stimulating factor mobilized peripheral blood stem cell donors.
Wu YF; Gu MH; Yang SH; Wang TF
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):204-210. PubMed ID: 31003920
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors.
Behfar M; Faghihi-Kashani S; Hosseini AS; Ghavamzadeh A; Hamidieh AA
Biol Blood Marrow Transplant; 2018 Apr; 24(4):866-870. PubMed ID: 29284143
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors.
Newell LF; Shoop KM; Knight RJ; Murray SN; Kwock RP; Jacoby CE; Slater S; Allen BE; Ottowa C; Cota B; Appel PL; Cook RJ; Maziarz RT; Meyers G
Cytotherapy; 2019 Jul; 21(7):725-737. PubMed ID: 31085121
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors.
Siddiq S; Pamphilon D; Brunskill S; Doree C; Hyde C; Stanworth S
Cochrane Database Syst Rev; 2009 Jan; (1):CD006406. PubMed ID: 19160282
[TBL] [Abstract][Full Text] [Related]
11. Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation.
Gattillo S; Marktel S; Rizzo L; Malato S; Malabarba L; Coppola M; Assanelli A; Milani R; De Freitas T; Corti C; Bellio L; Ciceri F
Transfusion; 2015 Aug; 55(8):1993-2000. PubMed ID: 25721167
[TBL] [Abstract][Full Text] [Related]
12. Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.
Teipel R; Oelschlägel U; Wetzko K; Schmiedgen M; Kramer M; Rücker-Braun E; Hölig K; von Bonin M; Heidrich K; Fuchs A; Ordemann R; Kroschinsky F; Bornhäuser M; Hütter G; Schmidt H; Ehninger G; Schetelig J; Heidenreich F
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2171-2177. PubMed ID: 29935214
[TBL] [Abstract][Full Text] [Related]
13. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
[TBL] [Abstract][Full Text] [Related]
14. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
[TBL] [Abstract][Full Text] [Related]
15. Medical and ethical considerations on hematopoietic stem cells mobilization for healthy donors.
Moalic-Allain V
Transfus Clin Biol; 2018 May; 25(2):136-143. PubMed ID: 29555414
[TBL] [Abstract][Full Text] [Related]
16. The effect of granulocyte colony stimulating factor on genotoxicity in allogeneic peripheral blood stem cell transplantation donors: a prospective case-control study.
Çakmaklı HF; Gökçe H; Söylemez E; Topçuoğlu P; Kayaaltı Z; İleri DT
Turk J Pediatr; 2023; 65(5):809-821. PubMed ID: 37853972
[TBL] [Abstract][Full Text] [Related]
17. [A Single-Center Analysis of the Use of G-CSF Combined with Plerixafor to Mobilize Peripheral Blood Hematopoietic Stem Cell from Healthy Related Donors in Allogeneic Hematopoietic Stem Cell Transplantation].
Chen J; Yuan LL; Zhang X; Qiao JL; Yin QX; Zhang YM; Yang XL; Cao XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):286-291. PubMed ID: 35123641
[TBL] [Abstract][Full Text] [Related]
18. Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors.
Hirsch B; Oseth L; Cain M; Trader E; Pulkrabek S; Lindgren B; Luo X; Clay M; Miller J; Confer D; Weisdorf D; McCullough J
Blood; 2011 Sep; 118(9):2602-8. PubMed ID: 21719598
[TBL] [Abstract][Full Text] [Related]
19. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
[TBL] [Abstract][Full Text] [Related]
20. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
